Wow, it's hard to think of a better example of a correlational study measuring something that would obviously be confounded by the thing being studied. Don't forget that most GLP-1 users are obese and many will continue to be after treatment (as it only causes a reduction in 10%-20% of body weight). And they're rich. So the headline is "rich obese people spend more in restaurants than average".
No shade on people taking the drug btw. I'm on tirzepatide myself.
No shade on people taking the drug btw. I'm on tirzepatide myself.